Skip to main content
PREFER
  • About
  • Partners
  • Case studies
  • Publications
  • Stakeholders
  • News
  • Contact
  • Recommendations
PREFER
  • About
  • Case studies
  • Events
  • Stakeholders
  • News
  • Partners
  • People
  • Publications
  • Contact
  • Recommendations
PREFER Annual meeting 2017 Registration Confirmation
Listen

Thank you for your registration!

Your registration has been received. If you have any questions, please contact carl@steinbeisser-management.com.

Print

Contact us

contact@imi-prefer.eu

communications@imi-prefer.eu

Follow us on twitter: @IMI_PREFER or YouTube

Subscribe to our newsletter

Disclaimer: This website and its contents reflects the PREFER project's view and not the view of IMI, the European Union or EFPIA.


 

Shortcuts

About PREFER

Our Stakeholders

Partners

ProjectPlace login

Dissemination proposal form

Accessibility report for imi-prefer.eu

PREFER

The Patient Preferences in Benefit-Risk Assessments during the Drug Life Cycle (PREFER) project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115966. This Joint Undertaking receives support from the European Union's Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).

This site is hosted by Uppsala University